IVD Market in BRIC Countries

Date: April 22, 2010
Pages: 155
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I401C777013EN
Leaflet:

Download PDF Leaflet

IVD Market in BRIC Countries
Report Description

The IVD markets of BRIC economies offer immense growth opportunities due to the increasing healthcare budgets in these nations, along with the increasing number of private corporate hospitals, and the rising income levels backed by a huge, untapped population bases. Despite regulatory hurdles and other restraints such as low consumer awareness and the absence of regulations concerning patient safety, the BRIC IVD market is expected to grow from $2.9 billion in 2009 to $7.2 billion-$7.5 billion in 2014 at a CAGR of ~19%-20% from 2009 to 2014. In comparison, the growth rate of the global IVD market is pegged at only ~5%-6% in the next five years. Our research indicates that China is expected to command the largest IVD market among all BRIC economies.

Scope of the Report

This report categorizes the BRIC IVD market on the basis of:
Geography: Brazil, Russia, India and China
Diagnostic Services: Hematology, immunology, microbiology, molecular diagnostics, urine analysis, etc.

Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 50 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 20 company profiles for each of its sub-segments.

What makes our reports unique?
  • We provide accurate business intelligence within the markets we study.
  • Each report is not only a representation of facts but a discussion of the markets we study. This we believe gives the reader on-ground information about the markets within diverse geographies.
  • The markets are studied through research interviews conducted with industry participants across the respective geographies. The studyincludes analytics over the data received for faster decision making.
  • We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.

Key questions answered
  • Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
  • What are market estimates and forecasts; which markets are doing well and which are not?
  • Where are the gaps and opportunities; what is driving the market?
  • Which are the key playing fields? Which are the winning edge imperatives?
  • How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.
EXECUTIVE SUMMARY

BRIC IVD MARKET OVERVIEW

1 INTRODUCTION


1.1 Key Take-Aways
1.2 Report Description
1.3 Stakeholders
1.4 Research Methodology & Key Assumptions
1.5 Market Segmentation And Definitions

2 SUMMARY

3 OVERVIEW OF THE GLOBAL IVD MARKET


3.1 Market Perspective

4 IVD MARKET OVERVIEW-BRAZIL

4.1 Scope
4.2 Drivers
4.3 Restraints
4.4 Trends
4.5 Market Size
4.6 Competitive Landscape
4.7 Market Forecast
4.8 Regulatory Body: Anvisa

5 IVD MARKET BY SEGMENTS -BRAZIL

5.1 Hematology
  5.1.1 Market Size And Forecast
  5.1.2 Competitive Landscape
5.2 Biochemistry
  5.2.1 Market Size And Forecast
  5.2.2 Competitive Landscape
5.3 Immunology
  5.3.1 Market Size And Forecast
  5.3.2 Competitive Landscape
5.4 Molecular Diagnostics
  5.4.1 Market Size And Forecast
  5.4.2 Competitive Landscape
5.5 Microbiology
  5.5.1 Market Size And Forecast
  5.5.2 Competitive Landscape
5.6 Hemostasis
  5.6.1 Market Size And Forecast
  5.6.2 Competitive Landscape
5.7 Cytology
  5.7.1 Market Size And Forecast
  5.7.2 Competitive Landscape
5.8 Cardiac Markers
  5.8.1 Market Size And Forecast
  5.8.2 Competitive Landscape
5.9 Hormones/Marking Tumors
  5.9.1 Market Size And Forecast
  5.9.2 Competitive Landscape

6 IVD MARKET OVERVIEW- RUSSIA

6.1 Market Scope
6.2 Drivers
6.3 Restraints
6.4 Trends
6.5 Market Size
6.6 Competitive Landscape
6.7 Market Forecast
6.8 Regulatory Body

7 IVD MARKET BY SEGMENTS - RUSSIA

7.1 Hemotology
  7.1.1 Market Size And Forecast
  7.1.2 Competitive Landscape
7.2 Biochemistry
  7.2.1 Market Size And Forecast
  7.2.2 Competitive Landscape
7.3 Immunology
  7.3.1 Market Size And Forecast
  7.3.2 Competitive Landscape
7.4 Molecular Diagnostics
  7.4.1 Market Size And Forecast
  7.4.2 Competitive Landscape
7.5 Microbiology
  7.5.1 Market Size And Forecast
  7.5.2 Competitive Landscape

8 IVD MARKET OVERVIEW- INDIA

8.1 Market Scope
8.2 Drivers
8.3 Restraints
8.4 Trends
8.5 Market Size
8.6 Competitive Landscape
8.7 Market Forecast
8.8 Regulations For Diagnostic Equipments In India

9 IVD MARKET BY SEGMENTS- INDIA

9.1 Hematology
  9.1.1 Market Size And Forecast
  9.1.2 Competitive Landscape
9.2 Biochemistry
  9.2.1 Market Size And Forecast
  9.2.2 Competitive Landscape
9.3 Immunology
  9.3.1 Market Size And Forecast
  9.3.2 Competitive Landscape
9.4 Molecular Diagnostics
  9.4.1 Market Size And Forecast
  9.4.2 Competitive Landscape
9.5 Urinalysis
  9.5.1 Market Size And Forecast
  9.5.2 Competitive Landscape

10 IVD MARKET OVERVIEW- CHINA

10.1 Market Scope
10.2 Drivers
10.3 Restraints
10.4 Trends
10.5 Market Size
10.6 Competitive Landscape
10.7 Market Forecast
10.8 Regulation Process For Medical Devices

11 IVD MARKET BY SEGMENTS- CHINA

11.1 Hematology
  11.1.1 Market Size And Forecast
  11.1.2 Competitive Landscape
11.2 Biochemistry
  11.2.1 Market Size And Forecast
  11.2.2 Competitive Landscape
11.3 Immunology
  11.3.1 Market Size And Forecast
  11.3.2 Competitive Landscape
11.4 Molecular Diagnostics
  11.4.1 Market Size And Forecast
  11.4.2 Competitive Landscape
11.5 Microbiology
  11.5.1 Market Size And Forecast
  11.5.2 Competitive Landscape

12 COMPETITIVE LANDSCAPE

12.1 Mergers & Acquisitions In IVD Market

13 COMPANY PROFILES

13.1 Abbott Diagnostics
13.2 Beckman Coulter INC
13.3 Becton, Dickinson & CO.
13.4 Biomйrieux SA
13.5 Bio-Rad Laboratories INC.
13.6 Diasorin Diagnostics SPA
13.7 Horiba LTD.
13.8 Mindray LTD
13.9 Ortho-Clinical Diagnostics INC
13.10 Oxoid LTD
13.11 Qiagen N.V
13.12 Roche Diagnostics LTD
13.13 Siemens Healthcare
13.14 Sysmex CORP

APPENDIX

Global IVD Patents

LIST OF TABLES

Summary Table Bric IVD Market 2007 – 2014 ($Millions)
Table 1 IVD Market Size Of Top Ten Countries (2008)
Table 2 Brazil IVD: Market Forecast By Segments 2007 – 2014 ($Millions)
Table 3 Russia Ageing Population
Table 4 Russia IVD: Market Forecast By Segments 2007 – 2014 ($Millions)
Table 5 India IVD: Market Forecasts By Segments 2007-2014 ($Millions)
Table 6 China IVD: Market Forecast2007-2014 ($Millions)
Table 7 New Product Launches In IVD Market (2009 – 2010 March)
Table 8 Mergers & Acquisitions In IVD Market (2008 – 2009)

LIST OF FIGURES

Figure 1 Brazil IVD Market Share
Figure 2 Brazil IVD: Market Revenue 2007-2014 ($Millions)
Figure 3 Brazil Hematology: Market Forecast 2007-2014 ($Millions)
Figure 4 Brazil Hematology: Competitive Landscape (2009)
Figure 5 Brazil Biochemistry: Market Forecast 2007-2014 ($Millions)
Figure 6 Brazil Biochemistry: Competitive Landscape (2009)
Figure 7 Brazil Immunology: Market Forecast 2007-2014 ($Millions)
Figure 8 Brazil Immunology: Competitive Landscape
Figure 9 Brazil Molecular Diagnostics: Market Forecast 2007-2014 ($Millions)
Figure 10 Brazil Molecular Diagnostics: Competitive Landscape
Figure 11 Brazil Microbiology: Market Forecast 2007-2014 ($Millions)
Figure 12 Brazil Microbiology: Competitive Landscape (2009)
Figure 13 Brazil Hemostasis: Market Forecast 2007-2014 ($Millions)
Figure 14 Brazil Hemostasis: Competitive Landscape (2009)
Figure 15 Brazil Cytology: Market Forecast 2007-2014 ($Millions)
Figure 16 Brazil Cytology: Competitive Landscape (2009)
Figure 17 Brazil Cardiac Markers: Market Forecast 2007-2014 ($Millions)
Figure 18 Brazil Cardiac Markers: Competitive Landscape (2009)
Figure 19 Brazil Hormones: Market Forecast 2007-2014 ($Millions)
Figure 20 Brazil Hormones: Competitive Landscape (2009)
Figure 21 Russia IVD: Competitive Landscape (2009)
Figure 22 Russia IVD: Market Forecast 2007-2014 ($Millions)
Figure 23 Russia Hematology: Market Forecast 2007-2014 ($Millions)
Figure 24 Russia Hematology: Competitive Landscape (2009)
Figure 25 Russia Biochemistry: Market Forecast 2007-2014 ($Millions)
Figure 26 Russia Biochemistry: Competitive Landscape (2009)
Figure 27 Russia Immunology: Market Forecast 2007-2014 ($Millions)
Figure 28 Russia Immunology: Competitive Landscape (2009)
Figure 29 Russia Molecular Diagnostics: Market Forecast 2007-2014 ($Millions)
Figure 30 Russia Molecular Diagnostics: Competitive Landscape (2009)
Figure 31 Russia Microbiology: Market Forecast 2007-2014 ($Millions)
Figure 32 Russia Microbiology: Competitive Landscape (2009)
Figure 33 Literacy In India: Percentage Of Total Population
Figure 34 Percentage Of The Total Population By Age
Figure 35 Urban Middle Class Household In India: Percentage Of Total By Income
Figure 36 Mortality Rate In India: Percentage Of Total By Diseases Type (1990-2020)
Figure 37 Number Of Policies By Type Of Coverage In Millions (2007)
Figure 38 Total Household Consumption: Percentage Of Total By Various Segments (1985-2025)
Figure 39 Market Shares Of Different Segments (2009)
Figure 40 India IVD: Growth Rate Of Different Segments (2009)
Figure 41 Indian IVD Market Competitive Landscape (2009)
Figure 42 India IVD: Market Forecast 2007-2014 ($Millions)
Figure 43 India Hematology: Market Forecast 2007-2014 ($Millions)
Figure 44 Indian Hematology Market Competitive Landscape (2009)
Figure 45 India Biochemistry: Market Forecast 2007-2014 ($Millions)
Figure 46 India Biochemistry: Competitive Landscape (2009)
Figure 47 India Immunology: Market Forecast 2007-2014 ($Millions)
Figure 48 India Immunology: Competitive Landscape (2009)
Figure 49 India Molecular Diagnostic: Market Forecast 2007-2014 ($Millions)
Figure 50 India Molecular Diagnostic: Competitive Landscape (2009)
Figure 51 India Urinalysis: Market Forecast 2007-2014 ($Millions)
Figure 52 India Urinalysis: Competitive Landscape (2009)
Figure 53 Market Of Different Segment (2009)
Figure 54 China IVD Competitive Landscape (2009)
Figure 55 China IVD: Market Forecast 2007-2014 ($Millions)
Figure 56 Process Of Device Registration
Figure 57 China Hematology: Market Forecast 2007-2014 ($Millions)
Figure 58 China Hematology: Competitive Landscape (2009)
Figure 59 China Biochemistry: Market Forecast 2007-2014 ($Millions)
Figure 60 China Biochemistry: Competitive Landscape (2009)
Figure 61 China Immunology: Market Forecast 2007-2014 ($Millions)
Figure 62 China Immunology: Competitive Landscape (2009)
Figure 63 China Molecular Diagnostic: Market Forecast 2007-2014 ($Millions)
Figure 64 Molecular Diagnostics: Competitive Landscape (2009)
Figure 65 China Microbiology: Market Forecast 2007-2014 ($Millions)
Figure 66 China Microbiology: Competitive Landscape (2009)
Figure 67 Competitive Analysis By Competitors (2009)
Skip to top


Ask Your Question

IVD Market in BRIC Countries
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: